Guardant Health Inc GH:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/01/22 EDT
43.66UNCH (UNCH)
Volume
15,445
Close
43.66quote price arrow up+3.32 (+8.23%)
Volume
816,927
52 week range
27.65 - 133.82
Loading...
  • Open40.39
  • Day High43.76
  • Day Low40.37
  • Prev Close40.34
  • 52 Week High133.82
  • 52 Week High Date09/02/21
  • 52 Week Low27.65
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap4.45B
  • Shares Out101.92M
  • 10 Day Average Volume1.39M
  • Dividend-
  • Dividend Yield-
  • Beta0.70
  • YTD % Change-56.35

KEY STATS

  • Open40.39
  • Day High43.76
  • Day Low40.37
  • Prev Close40.34
  • 52 Week High133.82
  • 52 Week High Date09/02/21
  • 52 Week Low27.65
  • 52 Week Low Date05/12/22
  • Market Cap4.45B
  • Shares Out101.92M
  • 10 Day Average Volume1.39M
  • Dividend-
  • Dividend Yield-
  • Beta0.70
  • YTD % Change-56.35

RATIOS/PROFITABILITY

  • EPS (TTM)-4.13
  • P/E (TTM)-10.58
  • Fwd P/E (NTM)-9.19
  • EBITDA (TTM)-402.014M
  • ROE (TTM)-60.76%
  • Revenue (TTM)391.09M
  • Gross Margin (TTM)67.74%
  • Net Margin (TTM)-102.44%
  • Debt To Equity (MRQ)213.02%

EVENTS

  • Earnings Date08/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Guardant Health Inc

There is no recent news for this security.

Profile

MORE
Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through the use of its blood-based tests, data sets, and advanced analytics. It has developed its Guardant360, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced-stage cancer. It also developed its Guardant Reveal liquid biopsy-based test for residual and recurring cancer to address the need for Stage II-II I colorectal cancer. Its Guardant360 test is...
Helmy Eltoukhy Ph.D.
Chairman of the Board, Co-Chief Executive Officer
Amirali Talasaz Ph.D.
President, Co-Chief Executive Officer, Director
Michael Bell
Chief Financial Officer
Address
SUITE D, 2686 MIDDLEFIELD ROAD
Redwood City, CA
94063
United States

Top Peers

SYMBOLLASTCHG%CHG
RARE
Ultragenyx Pharmaceutical Inc
62.65+2.99+5.01%
ARWR
Arrowhead Pharmaceuticals Inc
35.96+0.75+2.13%
GLPG
Galapagos NV
56.69+0.89+1.59%
APLS
Apellis Pharmaceuticals Inc
45.43+0.21+0.46%
NTLA
Intellia Therapeutics Inc
54.01+2.25+4.35%